Processa Pharmaceuticals, Inc.

NasdaqCM:PCSA Stock Report

Market Cap: US$2.8m

Processa Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:PCSA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
07 Feb 24BuyUS$51,526David YoungIndividual21,000US$2.45
06 Feb 24BuyUS$50,504David YoungIndividual20,000US$2.53
01 Feb 24BuyUS$9,525Patrick LinIndividual4,000US$2.40
30 Jan 24BuyUS$21,544Richland Fund LLCCompany8,000US$2.69
30 Jan 24BuyUS$27,000George NgIndividual10,000US$2.70

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of PCSA?
Owner TypeNumber of SharesOwnership Percentage
Institutions48,5511.49%
Public Companies62,5001.91%
Private Companies118,6843.63%
Individual Insiders189,7055.81%
General Public2,847,50487.2%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 165.3%.

Top Shareholders

Top 22 shareholders own 12.84% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
2.81%
David Young
91,691US$79.9k-7.75%no data
1.91%
Yuhan Corporation
62,500US$54.4k0%no data
1.73%
CorLyst, LLC
56,467US$49.2k0%no data
0.96%
Richland Fund LLC
31,232US$27.2k0%no data
0.95%
Young Plaisance Revocable Trust
30,985US$27.0k0%no data
0.89%
Patrick Lin
29,059US$25.3k1.56%no data
0.75%
The Vanguard Group, Inc.
24,433US$21.3k0%no data
0.67%
Sian Bigora
21,878US$19.1k1.95%no data
0.61%
George Ng
20,000US$17.4k0%no data
0.6%
Geode Capital Management, LLC
19,693US$17.2k14.3%no data
0.36%
Wendy Guy
11,857US$10.3k3.71%no data
0.2%
James Stanker
6,482US$5.6k5.92%no data
0.11%
Justin Yorke
3,737US$3.3k0%no data
0.11%
Tower Research Capital Europe Limited
3,640US$3.2k21.4%no data
0.088%
Geraldine Pannu
2,882US$2.5k0%no data
0.043%
Khoso Baluch
1,398US$1.2k0%no data
0.022%
James Neal
721US$628.00%no data
0.016%
UBS Asset Management AG
521US$453.90%no data
0.0047%
Wells Fargo & Company, Securities and Brokerage Investments
154US$134.00%no data
0.0026%
Allworth Financial, L.P.
85US$74.00%no data
0.00073%
Bank of America Corporation, Asset Management Arm
24US$20.814.3%no data
0.00003%
MacroView Investment Management LLC
1US$0.90%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 15:51
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Processa Pharmaceuticals, Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robin Garner KalleyCraig-Hallum Capital Group LLC
Raghuram SelvarajuH.C. Wainwright & Co.
François BriseboisOppenheimer & Co. Inc.